Requirement of MMP-3 in anchorage-independent growth of oral squamous cell carcinomas

Journal of Oral Pathology and Medicine

Volumn 36, Issue 7, 2007, Pages 430-435

  Liu, Shyun Yeu ^a,b,c   Liu, Young Chau ^a,d   Huang, Wen Tsung ^a   Huang, Guan Cheng ^a   Su, Hsiao Jing ^e,f   Lin, Mei Huei ^a,f  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d SHU TE UNIVERSITY   (Taiwan)

^e TAINAN SIN LAU HOSPITAL   (Taiwan)

^f CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Esophageal carcinoma; Matrix metalloproteinase 3; Oral squamous cell carcinoma; Stromelysin 1

Indexed keywords

[2,3 BIS (2 METHOXY 4 NITRO 5 SULFOPHENYL) 2H TETRAZOLIUM 5 CARBOXANILIDE]; AGAR; ANTISENSE OLIGODEOXYNUCLEOTIDE; STROMELYSIN; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

CARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL COUNT; CELL DIVISION; CELL LINE, TUMOR; DNA, ANTISENSE; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDICATORS AND REAGENTS; MATRIX METALLOPROTEINASE 3; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; TETRAZOLIUM SALTS; TRANSFECTION;

EID: 34447119536     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00524.x     Document Type: Article

References (28)

1. Saarialho-Kere UK. Patterns of matrix metalloproteinases and TIMP expression in chronic ulcers. Arch Dermatol Res 1998 290 (Suppl. S47 54.
2. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993 42 : 197 250.
3. Woessner JF. The family of matrix metalloproteinases. Ann N Y Acad Sci 1994 732 : 11 30.
4. Mccawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore Curr Opin Cell Biol 2001 13 : 534 40.
5. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002 2 : 161 74.
6. Yoshida K, Tsujino T, Yasui W, et al. Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-alpha in human gastric carcinoma cell line MKN-28. Jpn J Cancer Res 1990 81 : 793 8.
7. Baker EA. Leaper DJ. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Repair Regen 2000 8 : 392 8.
8. Gomis-Ruth FX, Maskos K, Betz M, et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 1997 389 : 77 81.
9. Sternlicht MD, Bissell MJ, Werb Z. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 2000 19 : 1102 13.
10. Wright JH, Mcdonnell S, Portella G, et al. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carcinogen 1994 10 : 207 15.
11. Inuzuka K, Ogata Y, Nagase H, et al. Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma. J Surg Res 2000 93 : 211 8.
12. Sternlicht MD, Lochter A, Sympson CJ, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999 98 : 137 46.
13. Radisky DC, Levy DD, Littlepage LE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005 436 : 123 7.
14. Kusukawa J, Sasaguri Y, Morimatsu M, et al. Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg 1995 53 : 530 4.
15. Lijnen HR, Arza B, Van Hoef B, et al. Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3). J Biol Chem 2000 275 : 37645 50.
16. Kusukawa J, Harada H, Shima I, et al. The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Eur J Cancer, B, Oral Oncol, 1996 32B : 217 21.
17. Birkedal-Hansen B, Pavelic ZP, Gluckman JL, et al. MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Oral Dis 2000 6 : 376 82.
18. Nagata M, Fujita H, Ida H, et al. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 2003 106 : 683 9.
19. Huang GC, Liu SY, Lin MH, et al. The synergistic cytotoxicity of cisplatin and taxol in killing oral squamous cell carcinoma. Jpn J Clin Oncol 2004 34 : 499 504.
20. Liu YC, Chen SC, Chang C, et al. Platelet-derived growth factor is an autocrine stimulator for the growth and survival of human esophageal carcinoma cell lines. Exp Cell Res 1996 228 : 206 11.
21. Liu YC, Leu CM, Wong FH, et al. Autocrine stimulation by insulin-like growth factor I is involved in the growth, tumorigenicity and chemoresistance of human esophageal carcinoma cells. J Biomed Sci 2002 9 : 665 74.
22. Liu SY, Lin MH, Yang SC, et al. Areca quid chewing enhances the expression of salivary matrix metalloproteinase-9. J Formos Med Assoc 2005 104 : 113 9.
23. Liu SY, Lin MH, Yang SC, et al. Increased expression of matrix metalloproteinase-2 in oral cells after short-term stimulation and long-term usage of areca quid. J Formos Med Assoc 2005 104 : 390 7.
24. Boudreau N, Sympson CJ, Werb Z, et al. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995 267 : 891 3.
25. Lovdahl C, Thyberg J, Cercek B, et al. Antisense oligonucleotides to stromelysin mRNA inhibit injury-induced proliferation of arterial smooth muscle cells. Histol Histopathol 1999 14 : 1101 12.
26. Fray MJ, Dickinson RP, Huggins JP, et al. A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers. J Med Chem 2003 46 : 3514 25.
27. Shima I, Sasaguri Y, Kusukawa J, et al. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 1992 70 : 2747 53.
28. Zhang J, Jin X, Fang S, et al. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis 2004 25 : 2519 24.